Solid Biosciences Inc.
Total Trades
68
Buys
5
Sells
37
Largest Trade
N/A
Insiders
12
Institutional Funds
91
Inst. Value
$1M+
Activist Filings
47
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Howton David T | COO | SELL | $100K–$500K | 19K | $6.44 | Feb 6, 2026 |
| Cumbo Alexander | President and CEO | SELL | $100K–$500K | 49K | $6.44 | Feb 6, 2026 |
| Ganot Ilan | Director | SELL | $15K–$50K | 7K | $6.44 | Feb 6, 2026 |
| Tan Kevin | CFO & Treasurer | SELL | $50K–$100K | 15K | $6.44 | Feb 6, 2026 |
| Brooks Gabriel | Chief Medical Offi… | SELL | $50K–$100K | 13K | $6.44 | Feb 6, 2026 |
| Hanrahan Jessie | Chief Regulatory O… | SELL | $50K–$100K | 12K | $6.44 | Feb 6, 2026 |
| Herzich Paul | CTO | SELL | $50K–$100K | 11K | $6.44 | Feb 6, 2026 |
| Tan Kevin | CFO & Treasurer | EXERCISE | N/A | 90K | — | Feb 3, 2026 |
| Tan Kevin | CFO & Treasurer | SELL | $100K–$500K | 27K | $6.44 | Feb 3, 2026 |
| Cumbo Alexander | President and CEO | EXERCISE | N/A | 270K | — | Feb 3, 2026 |
| Cumbo Alexander | President and CEO | SELL | $500K+ | 80K | $6.44 | Feb 3, 2026 |
| Hanrahan Jessie | Chief Regulatory O… | EXERCISE | N/A | 83K | — | Feb 3, 2026 |
| Hanrahan Jessie | Chief Regulatory O… | SELL | $100K–$500K | 27K | $6.44 | Feb 3, 2026 |
| Brooks Gabriel | Chief Medical Offi… | EXERCISE | N/A | 87K | — | Feb 3, 2026 |
| Brooks Gabriel | Chief Medical Offi… | SELL | $100K–$500K | 28K | $6.44 | Feb 3, 2026 |
| Howton David T | COO | SELL | $100K–$500K | 38K | $6.44 | Feb 3, 2026 |
| Howton David T | COO | EXERCISE | N/A | 122K | — | Feb 3, 2026 |
| Herzich Paul | CTO | SELL | $100K–$500K | 26K | $6.44 | Feb 3, 2026 |
| Herzich Paul | CTO | EXERCISE | N/A | 80K | — | Feb 3, 2026 |
| Ganot Ilan | Director | SELL | $1K–$15K | 191 | $6.59 | Jan 30, 2026 |
| Ganot Ilan | Director | EXERCISE | N/A | 4K | — | Jan 30, 2026 |
| Tan Kevin | CFO & Treasurer | SELL | $15K–$50K | 6K | $5.27 | Jan 13, 2026 |
| Tan Kevin | CFO & Treasurer | EXERCISE | N/A | 11K | — | Jan 13, 2026 |
| Ganot Ilan | Director | SELL | $1K–$15K | 1K | $5.43 | Jan 6, 2026 |
| Ganot Ilan | Director | EXERCISE | N/A | 3K | — | Jan 6, 2026 |
| Howton David T | COO | SELL | $15K–$50K | 5K | $5.11 | Dec 4, 2025 |
| Howton David T | COO | EXERCISE | N/A | 13K | — | Dec 4, 2025 |
| Cumbo Alexander | President and CEO | SELL | $50K–$100K | 11K | $5.11 | Dec 4, 2025 |
| Cumbo Alexander | President and CEO | EXERCISE | N/A | 29K | — | Dec 4, 2025 |
| Hanrahan Jessie | Chief Regulatory O… | SELL | $15K–$50K | 4K | $5.11 | Dec 4, 2025 |
| Hanrahan Jessie | Chief Regulatory O… | EXERCISE | N/A | 12K | — | Dec 4, 2025 |
| Herzich Paul | CTO | EXERCISE | N/A | 7K | — | Dec 4, 2025 |
| Herzich Paul | CTO | SELL | $1K–$15K | 3K | $5.11 | Dec 4, 2025 |
| Ganot Ilan | Director | SELL | $1K–$15K | 3K | $4.12 | Nov 13, 2025 |
| Brooks Gabriel | Chief Medical Offi… | SELL | $15K–$50K | 3K | $5.96 | Oct 21, 2025 |
| Brooks Gabriel | Chief Medical Offi… | EXERCISE | N/A | 10K | — | Oct 21, 2025 |
| Kahn Clare | Director | BUY | $1K–$15K | 2K | $5.34 | Mar 13, 2025 |
| Bain Capital Life Sciences Investors, LLC | 10% Owner | BUY | $1M+ | 1.0M | $4.03 | Feb 21, 2025 |
| PERCEPTIVE ADVISORS LLC | Director | BUY | $1M+ | 5.0M | $4.03 | Feb 21, 2025 |
| Ganot Ilan | Director | SELL | <$1K | 144 | $3.11 | Jan 29, 2025 |
| Ganot Ilan | Director | EXERCISE | N/A | 4K | — | Jan 29, 2025 |
| Tan Kevin | CFO & Treasurer | SELL | $15K–$50K | 4K | $3.89 | Jan 13, 2025 |
| Tan Kevin | CFO & Treasurer | EXERCISE | N/A | 11K | — | Jan 13, 2025 |
| Ganot Ilan | Director | EXERCISE | N/A | 3K | — | Jan 7, 2025 |
| Ganot Ilan | Director | SELL | $1K–$15K | 1K | $4.31 | Jan 7, 2025 |
| Hanrahan Jessie | Chief Regulatory O… | SELL | $15K–$50K | 5K | $5.60 | Dec 4, 2024 |
| Hanrahan Jessie | Chief Regulatory O… | EXERCISE | N/A | 12K | — | Dec 4, 2024 |
| Cumbo Alexander | President and CEO | SELL | $50K–$100K | 11K | $5.60 | Dec 4, 2024 |
| Cumbo Alexander | President and CEO | EXERCISE | N/A | 29K | — | Dec 4, 2024 |
| Howton David T | COO | SELL | $15K–$50K | 5K | $5.60 | Dec 4, 2024 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 91 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 11.8M | $1M+ | SH |
| Bain Capital Life Sciences Investors, LLC | 7.9M | $1M+ | SH |
| Siren, L.L.C. | 7.7M | $1M+ | SH |
| RA CAPITAL MANAGEMENT, L.P. | 5.8M | $1M+ | SH |
| Point72 Asset Management, L.P. | 2.4M | $1M+ | SH |
| Redmile Group, LLC | 1.9M | $1M+ | SH |
| Alyeska Investment Group, L.P. | 1.7M | $1M+ | SH |
| Nantahala Capital Management, LLC | 1.6M | $1M+ | SH |
| Monashee Investment Management LLC | 1.3M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1M | $1M+ | SH |
| STATE STREET CORP | 1.1M | $1M+ | SH |
| Finepoint Capital LP | 961K | $1M+ | SH |
| UBS Group AG | 881K | $1M+ | SH |
| Birchview Capital, LP | 706K | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 627K | $1M+ | SH |
| Ally Bridge Group (NY) LLC | 414K | $1M+ | SH |
| BALYASNY ASSET MANAGEMENT L.P. | 361K | $1M+ | SH |
| PANAGORA ASSET MANAGEMENT INC | 227K | $1M+ | SH |
| APIS CAPITAL ADVISORS, LLC | 196K | $1M+ | SH |
| Schonfeld Strategic Advisors LLC | 183K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Adage Capital Management, L.P.
SC 13G/A · Feb 12, 2026
1.8%
1.4M shares
Adage Capital Management, L.P.
SC 13G/A · Nov 13, 2025
5.1%
4.0M shares
SC 13D/A · Aug 14, 2025
9.9%
8.0M shares
SC 13G/A · Aug 14, 2025
0.0%
0 shares
SC 13G · Jul 18, 2025
6.1%
4.7M shares
SC 13G/A · May 15, 2025
2.3%
1.8M shares
Adage Capital Management, L.P.
SC 13G · May 12, 2025
8.7%
6.7M shares
SC 13G/A · Apr 17, 2025
8.3%
6.4M shares
SC 13G · Feb 25, 2025
7.6%
5.8M shares
SC 13D/A · Feb 21, 2025
0.7%
529K shares
SC 13D/A · Feb 21, 2025
9.9%
8.0M shares
SC 13D/A · Feb 21, 2025
15.6%
11.9M shares
SC 13G/A · Feb 14, 2025
0.0%
0 shares
SC 13G/A · Feb 12, 2025
8.2%
3.3M shares
SC 13D/A · Nov 15, 2024
693.5M shares
SC 13G · Nov 14, 2024
7.3%
2.8M shares
SC 13G/A · Nov 14, 2024
0.0%
0 shares
SC 13G/A · Nov 12, 2024
6.2%
240.8M shares
Adage Capital Management, L.P.
SC 13G/A · Nov 12, 2024
4.5%
1.8M shares
SC 13G/A · Nov 1, 2024
2.9%
1.1M shares
SC 13G/A · Aug 2, 2024
6.5%
2.5M shares
SC 13D/A · Jun 12, 2024
11.3%
4.4M shares
SC 13D/A · Jun 12, 2024
1.4%
529K shares
SC 13G · Jun 5, 2024
5.2%
2.0M shares
SC 13G · Jan 22, 2024
7.3%
2.7M shares
SC 13D/A · Jan 12, 2024
18.6%
6.9M shares
SC 13D/A · Jan 12, 2024
1.4%
529K shares
SC 13G · Jan 12, 2024
6.1%
2.3M shares
SC 13D/A · Jan 11, 2024
11.7%
4.3M shares
SC 13D/A · Jan 10, 2024
2.6%
529K shares
SC 13G/A · Feb 13, 2023
1.5%
285K shares
Suvretta Capital Management, LLC
SC 13G/A · Feb 13, 2023
0.0%
0 shares
SC 13G/A · Feb 9, 2023
0.0%
0 shares
SC 13D/A · Feb 3, 2023
17.9%
3.5M shares
Camber Capital Management LP 42-1693587
SC 13G · Dec 12, 2022
7.3%
1.4M shares
SC 13D/A · Dec 6, 2022
17.9%
3.5M shares
SC 13D/A · Dec 5, 2022
17.6%
3.4M shares
SC 13D/A · Dec 5, 2022
2.7%
529K shares
SC 13D/A · Oct 4, 2022
11.0%
12.4M shares
SC 13D/A · Oct 3, 2022
7.0%
7.9M shares
SC 13D/A · Sep 2, 2022
11.9%
13.5M shares
SC 13G · Aug 31, 2022
5.0%
5.7M shares
SC 13D/A · Aug 18, 2022
7.0%
7.9M shares
SC 13G · Jul 8, 2022
2.5%
2.9M shares
SC 13G/A · Feb 14, 2022
0.534 shares
SC 13G/A · Feb 14, 2022
8.3%
9.2M shares
Suvretta Capital Management, LLC
SC 13G/A · Feb 11, 2022
5.7%
6.3M shares